Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 13, 2020

Primary Completion Date

March 1, 2022

Study Completion Date

March 1, 2022

Conditions

Solid Tumor

Interventions

OTHER

68Ga-DX600 PET/CT

DX600, labeled with 68Ga will be used as a molecular imaging tracer for PET/CT scanning

Trial Locations (1)

Ethics Committee of Peking University Cancer Hospital, Beijing

All Listed Sponsors

lead

Peking University Cancer Hospital & Institute

OTHER

NCT04422457 - Specific Molecular Imaging of DX600 Labeled by PET Radionuclide Targeting ACE2 in Patients | Biotech Hunter | Biotech Hunter